NEW YORK (GenomeWeb News) – Shares of Sequenom rose 17.6 percent to close at $5.95 in Thursday trade on the Nasdaq after Cantor Fitzgerald initiated coverage of the firm with a “buy” rating.
 
Cantor Fitzgerald also placed a $12 price target on Sequenom’s shares and expects the firm to become profitable in 2010. The Cantor Fitzgerald analyst cited the revenue growth potential of Sequenom’s MassArray system.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.